News on P Less than company from BioPortfolio.com http://www.BioPortfolio.com Consolidated P Less than company news from BioPortfolio.com Wed, 10 Feb 2010 12:11:52 GMT en Ask the Experts: Feb. 10, 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039329&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039329&THISHREF=http://c.moreover.com/click/here.pl%3fz2538030433%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039329&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039329&THISHREF=http://c.moreover.com/click/here.pl%3fz2538030433%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAdvance for HIM: Delcath Signs First Partner Agreement in Asiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034846&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034846&THISHREF=http://c.moreover.com/click/here.pl%3fz2536010969%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034846&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034846&THISHREF=http://c.moreover.com/click/here.pl%3fz2536010969%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: New Funding Validates Importance of Divergences Work on Nematodeshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036285&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036285&THISHREF=http://c.moreover.com/click/here.pl%3fz2536551079%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036285&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036285&THISHREF=http://c.moreover.com/click/here.pl%3fz2536551079%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAFP via Yahoo!: Genta commences Phase 2 trial of tesetaxel on first subjecthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034650&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034650&THISHREF=http://c.moreover.com/click/here.pl%3fz2535909558%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034650&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034650&THISHREF=http://c.moreover.com/click/here.pl%3fz2535909558%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Genta commences treatment in tesetaxel Phase 2 trial for advanced melanomahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033220&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033220&THISHREF=http://c.moreover.com/click/here.pl%3fz2535076243%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033220&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033220&THISHREF=http://c.moreover.com/click/here.pl%3fz2535076243%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inchttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033601&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033601&THISHREF=http://c.moreover.com/click/here.pl%3fz2535286184%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033601&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033601&THISHREF=http://c.moreover.com/click/here.pl%3fz2535286184%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRBC Dain Rauscher: Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033456&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033456&THISHREF=http://c.moreover.com/click/here.pl%3fz2535210104%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033456&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033456&THISHREF=http://c.moreover.com/click/here.pl%3fz2535210104%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStockHouse USA: Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033455&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033455&THISHREF=http://c.moreover.com/click/here.pl%3fz2535209989%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033455&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033455&THISHREF=http://c.moreover.com/click/here.pl%3fz2535209989%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStockHouse USA: HC rejects Bayer's patent plea on cancer drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037333&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037333&THISHREF=http://c.moreover.com/click/here.pl%3fz2537033179%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037333&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037333&THISHREF=http://c.moreover.com/click/here.pl%3fz2537033179%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Standard India: SANUWAVEs PACE Technology is a Novel, Safe and Cost-Effective Method to Treat Severe Burns without Surgery or Skin Graftinghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034948&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034948&THISHREF=http://c.moreover.com/click/here.pl%3fz2536060135%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034948&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034948&THISHREF=http://c.moreover.com/click/here.pl%3fz2536060135%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Phase II Study of Sunitinib in Patients With Metastatic Urothelial Cancer [Genitourinary Cancer]http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033629&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033629&THISHREF=http://c.moreover.com/click/here.pl%3fz2535297372%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033629&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033629&THISHREF=http://c.moreover.com/click/here.pl%3fz2535297372%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comJournal of Clinical Oncology: Effects of Tamoxifen and Exemestane on Cognitive Functioning of Postmenopausal Patients With Breast Cancer: Rehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033620&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033620&THISHREF=http://c.moreover.com/click/here.pl%3fz2535295478%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033620&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033620&THISHREF=http://c.moreover.com/click/here.pl%3fz2535295478%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comJournal of Clinical Oncology: Life Sciences: New findings reported from Exponent, Inc. describe advances in life scienceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033361&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033361&THISHREF=http://c.moreover.com/click/here.pl%3fz2535162840%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033361&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033361&THISHREF=http://c.moreover.com/click/here.pl%3fz2535162840%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Euphoric Pharmaceuticals (P) Ltd-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029992&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029992&THISHREF=http://c.moreover.com/click/here.pl%3fz2533370528%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029992&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029992&THISHREF=http://c.moreover.com/click/here.pl%3fz2533370528%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Gary Pharmaceuticals P Limited-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029048&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029048&THISHREF=http://c.moreover.com/click/here.pl%3fz2532972735%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029048&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=P%20Less%20than%20company&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029048&THISHREF=http://c.moreover.com/click/here.pl%3fz2532972735%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: